Conference
COVID-19: the contribution of NOVA - Lessons learned, perspectives for the future
The NOVAhealth Chronic Disease and Infection group launches its 5 Conference. In this meeting we will discuss the contributions that NOVA's Organic Units have made during the COVID-19 pandemic, specifically the lessons learned, and the ideas being devised for the future.
Our conference aims to fostering the presentation of novel scientific achievements and the development of cross-disciplinary collaborations during the COVID-19 pandemic.
This international conference is intended to reach a broad audience including teaching staff, researchers, students at all levels, and the general public. It aims to present research in various formats and perspectives, allowing a wide interaction and discussion among participants and raising the society awareness on the topic.
The session will take place at the Rectorate of Universidade NOVA de Lisboa on October 14th 2022 from 9am to 1pm.
Poster submission
Authors interested in presenting their research on the conference topic should submit their work (instructions and selection criteria).
IMPORTANT DATES
Poster submission: October 10, 2022.
Accepted abstracts will be included in the Conference Book and posters will be available on the online platform. A “Best Poster Award” will be granted during the conference.
Any additional questions send an email to miragaia@itqb.unl.pt.
Organizing Committee
Ligia M. Saraiva
ITQB NOVA
Maria Miragaia
ITQB NOVA
José Luiz Telles
ENSP NOVA
Maria Grazia Rossi
FCSH NOVA
Cláudia Conceição
IHMT NOVA
NOVAhealth Group
NOVA Saúde Chronic Disease and Infection Group promotes research, evidence-based knowledge and awareness to develop new effective and sustainable approaches and solutions to these problems. The group fosters academic and social discussion in order to respond to the daily challenges pose to patients, as well as, to the health systems and their professionals.
Program
Moderators: Paulo Paixão, FCM/NMS; Maria Miragaia, ITQB
09:00 – Opening: João Sàágua, Rector NOVA
09:15 – ITQB NOVA, Claudio Soares
09:25 – IHMT NOVA, Miguel Viveiros
09:35 – FCT, Pedro Viana Baptista
09:45 – Discussion with Talk Speakers
10:00 – NMS, Paulo Pereira
10:10 – ENSP-NOVA, Andreia Leite
10:20 – NOVA FCSH, Rute Costa, Raquel Silva and Sara Carvalho
10:30 – Discussion with Talk Speakers
10:45 – Coffee Break
11:05 – NLS, Cristina Queiroz
11:15 – NOVA SBE, Joana Pestana
11:25 – NOVA IMS, Pedro Simões Coelho and Jorge M. Mendes
11:35 – Pfizer, Pedro Coelho Lopes
11:45 – Discussion with Talk Speakers
12:05 – Research Grant NOVAhealth Chronic Disease and Infection 2022 - Best Poster award
12:30 – Concluding remarks
Speakers
Professor in Biomedical Sciences - Medical Microbiology and Global Health, Vice-Director of the Institute of Hygiene and Tropical Medicine, NOVA University of Lisbon, Portugal.
Devoted to the early diagnosis and molecular epidemiology of TB and new therapeutics for MDRTB and XDRTB. Specialist in the diagnosis of antibiotic resistance in bacteria by phenotypic and genotypic assays.
Executive committee member of the Study Group for Mycobacterial Infections of ESCMID. Scientific Coordinator of “Ciência LP - Center for Advanced Training in Fundamental Sciences for Scientists from Portuguese-speaking Countries” (UNESCO Category 2 Center) and Vice-President of the Portuguese Society for Microbiology. Author/co-author of over 200 scientific papers in peer reviewed journals and books in mycobacteriology, resistance to antibiotics and microbial genetics.
Pedro Viana Baptista (PVB) graduated from Faculdade Farmácia, Universidade de Lisboa (1996) and a PhD in Human Molecular Genetics from the School of Pharmacy, University of London (2000). Took up a position at Faculdade de Ciências e Tecnologia, Universidade NOVA de Lisboa (FCT-NOVA) in 2001. PVB created the Nanomedicine Group focused on nanotechnology for precision therapeutics studies and molecular diagnostics, developing conceptual nanotheranostics combinatory approaches against cancer. Since 2018, PVB has been Full Professor of Life Sciences - Molecular Genetics & Nanomedicine at Dept Life Sciences (FCT-NOVA).
PVB has been leading/involved in more than 22 national and European projects, publishing 13 book chapters, >200 papers, and several patents. The Nanomedicine Group is part of UCIBIO (Research Unit in Biomolecular Sciences) and Associated Laboratory i4HB. PVB has participated in several international networks in the field of Nanomedicine/Nanobiotechnology, advisor of more than 9 young post-doc researchers, supervising 15 PhD students and >40 MSc students. PVB is co-founder and Chief Scientific Officer (CSO) of Nano4 Global Lda – a NOVA spin off.
At FCT-NOVA, PVB is member of the Scientific Council, Head of Department of Life Sciences and President of the Ethics Committee.
Paulo Pereira is a Group Leader at Nova Medical School and is currently the Coordinator of the research unit iNOVA4Health at NOVA Medical School and the associate Laboratory LS4Future.
From 2020 to 2022 he was the President of the Executive Board of CEDOC-NMS. PP received a PhD in Cell Biology (1997) and studied and worked at University of Coimbra, University College of London and Tufts University (Boston).
He moved in 2012 to Lisbon where he held an administrative appointment as vice-president of FCT and, subsequently, established himself as a PI at CEDOC-NMS in 2016.
PP made some important contribution on the role of proteotoxic stress in age-related diseases such as age-related macular degeneration. In the last 15 years PP published 47 peer reviewed scientific papers, was the PI in 8 competitively funded research grants, supervised 17 PhD students and 6 postdocs.
Public Health Medical Doctor at the National Institute for Health Doctor Ricardo Jorge and Invited Assistant Professor at NOVA National School of Public Health. Member of the Comprehensive Health Research Center and Vaccination Technical Committee.
Andreia Leite is a public health medical doctor (Faculty of Medicine, University of Lisbon), Master in Public Health (Umeå University), MSc in Biostatistics (Faculty of Sciences, University of Lisbon) and holds a PhD on vaccine epidemiology (London School of Hygiene and Tropical Medicine).
She was involved on the study of COVID-19 epidemiology and provided scientific advice to the Portuguese Government regarding pandemic control. She supervises MSc students, PhD students and internships on public Health research.
She has co-authored more than 20 scientific papers and has 180 citations. Her research interests include surveillance systems development, population based epidemiological studies and evaluation of causal effects of public health interventions.
Full Professor at the NOVA School of Law. Specialist in Legal and Political Sciences. Graduated (1980), Master (1986) and PD (1998) in Law from the Lisbon University, Faculty of Law. “Agregação” (2012) from the Oporto University, Faculty of Law.
She was a guest researcher in the Max-Planck Institute of Comparative Public Law and Public International Law, Heidelberg in 1986-1987 and 1992-1996.
She is a member of the following research centres, associations and institutes: CEDIS, Centro de Investigação & Desenvolvimento sobre Direito e Sociedade, NOVA School of Law; Portuguese Association of Constitutional Law, affiliated to the International Association of Constitutional Law / Association Internationale de Droit Constitutionnel (IACL-AIDC); Institute of Comparative Luso-Brazilian Law, with headquarters in Rio de Janeiro, Federative Republic of Brazil (IDCLB); Portuguese Association of Law Theory, Philosophy of Law and Social Philosophy, affiliated to the “International Association for the Philosophy of Law and Social Philosophy” (IVR); Portuguese Society of Criminology, affiliated to the “International Society of Criminology” (ISC).
Research Areas: Constitutional Law; Comparative Public Law; Fundamental Rights; Social Fundamental Rights; Constitutional Justice; International Protection of Human Rights; International Law and International Relations".
Joana is currently pursuing a PhD in Economics at the NOVA School of Business and Economics in Lisbon, Portugal.
As part of her PhD, she was a Research Fellow in the training network Improving Quality of Care in Europe funded under a Marie Skłodowska-Curie grant from the European Commission that aimed at improving the quality and performance of European health care systems.
Joana was a visiting researcher at the Erasmus School of Health Policy & Management from the Erasmus university Rotterdam. She also works as a researcher on projects with the Nova Health Economics and Management Knowledge Center.
Her research focuses on the variation in the performance and quality of primary health care and the integration of mental health services in primary care organizations. She is also a member of the Portuguese Association of Health Economics.
Pedro Simões Coelho is currently Full Professor and President of the Scientific Council of NOVA Information Management School (NOVA IMS). He has also been Visiting Professor at the Faculty of Economics – Ljubljana University (FELU), data and information coordinator at the Clinical Research Unit at Universidade Nova de Lisboa, member of the International Advisory Board for Abu Dhabi Statistical System and Senior Consultant to the European Commission.
He is the author of more than two hundred studies and projects including the SNS Sustainability Index, as well as numerous projects of impact assessment specifically in health arena. He is author of more than a hundred scientific publications. He has been a consultant for several organizations, including Eurostat, Banco de Portugal, the National Institute of Statistics, OECD and the European Commission.
Pedro Coelho Lopes is currently Medical Lead at Pfizer Portugal for the hospital/anti-infectives therapeutic area.
He holds a degree in Medicine by the Medical School of Lisbon University and a post-graduation in Marketing and Management by the Portuguese Catholic University. He has developed his career between clinical practice and pharmaceutical medicine where he had played several roles in the medical field in different pharmaceutical companies and therapeutic areas.
Over the past 12 years he had developed several projects on health literacy targeting lay population.